XSES
C8R
Market cap24mUSD
Oct 09, Last price
0.02SGD
1D
-6.25%
1Q
-31.82%
Jan 2017
25.00%
IPO
-97.67%
Name
Jiutian Chemical Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio encompasses Dimethylformamide (DMF), a vital raw material for polyurethane, pharmaceutical, and agrochemical sectors, also serving as an absorbent in electronics, acrylic fiber production, and pharmaceuticals. They also produce Methylamine, an essential organic chemical feedstock widely used across various industries including agricultural chemicals, medicines, fuels, synthetic resins, and leather processing, as well as in chemical fiber solvents, activating agents, and photography. Another offering is Sodium Hydrosulfite, a crystalline powder with applications in water treatment, gas purification, cleaning, stripping, and industrial processes for textiles, leather, food, polymers, and photography. Furthermore, Jiutian supplies industrial and consumable Carbon Dioxide for aerated drinks, tobacco, and vegetable preservation. Advanced products include Oxygen-18, an oxygen isotope critical for producing fluorodeoxyglucose, and Deuterium Depleted Water, known for its use in inhibiting cancer cell growth, alongside industrial methanol. The group is also involved in the sales of derivative chemical products and conducts research and development in isotope technology.
Key people
Aijun Xu
Non-Executive Non-Independent Chairman of the Board · since 2024
Hongguang Wei
Acting Chief Executive Officer and General Manager of Subsidiaries · since 2021
Han Kiat Ng
Group Financial Controller · since 2017
Chee Seng Lee
Executive Director
Qingwu He
Head of Marketing · since 2019
Yiquan Chen
Vice General Manager of Subsidiaries - Production and Technology
Zong Hu
Financial Controller of Subsidiaries · since 2021
Wai Ming Chiang
Company Secretary · since 2025
Fudong Song
Non-Executive and Non-Independent Director · since 2022
Eng Kheng Koh
Non-Executive Lead Independent Director · since 2024
Non-Executive Independent Director · since 2024
Gang Wang
Non-Executive Independent Director · since 2024
Hongli Wang
Non-Executive Independent Director · since 2024
Zilong Wang
Non-Executive Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||